Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-31
2007-07-31
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S448000
Reexamination Certificate
active
11230729
ABSTRACT:
The invention is directed to a method of treating, preventing, or inhibiting a Hepatitis C viral infection in a mammal comprising contacting the mammal with an effective amount of a compound of the formula:wherein substitutions at R1-R13, m and Y are set forth in the specification.
REFERENCES:
patent: 5830911 (1998-11-01), Failli et al.
patent: 0 307 077 (1989-03-01), None
patent: WO 98/38986 (1998-09-01), None
patent: WO 2005/072408 (2005-08-01), None
Davis et al. J. Med. Chem. 1998, 41, 451-467.
STN search result 7 of 7.
Gopalsamy, et al. “Identification of carbazole and cyclopentaindole derivatives as inhibitors of HCV RNA dependent RNA polymerase.” Abstracts of papers Am. Chem. Soc., vol. 229, part 2, Mar. 2005, p. U167.
Raj, K., et al. “Nu-&Omicron-dialkylaminoalkylcarbaxoles as potential antiviral agents,” Indian J. of Chem., Section B: Organic, vol. 14B, No. 5, May 1, 1976, pp. 371-373.
Ciszewski Gregory Mark
Gopalsamy Ariamala
Park Kaapjoo
Shi Mengxiao
Chu Yong
Saeed Kamal A.
Wyeth
LandOfFree
Carbazole and cyclopentaindole derivatives to treat... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbazole and cyclopentaindole derivatives to treat..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbazole and cyclopentaindole derivatives to treat... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3760898